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Abstract: The diversity of HIV-1 and its propensity to generate escape mutants present 
fundamental challenges to control efforts, including HIV vaccine design. Intra-host 
diversification of HIV is determined by immune responses elicited by an HIV-infected 
individual over the course of the infection. Complex and dynamic patterns of transmission 
of HIV lead to an even more complex population viral diversity over time, thus presenting 
enormous challenges to vaccine development. To address inter-patient viral evolution over 
time, a set of 653 unique HIV-1 subtype C gag sequences were retrieved from the LANL 
HIV Database, grouped by sampling year as <2000, 2000, 2001–2002, 2003, and  
2004–2006, and analyzed for the site-specific frequency of translated amino acid residues. 
Phylogenetic analysis revealed that a total of 289 out of 653 (44.3%) analyzed sequences 
were found within 16 clusters defined by aLRT of more than 0.90. Median (IQR) inter-
sample diversity of analyzed gag sequences was 8.7% (7.7%; 9.8%). Despite the 
heterogeneous origins of analyzed sequences, the gamut and frequency of amino acid 
residues in wild-type Gag were remarkably stable over the last decade of the HIV-1 
subtype C epidemic. The vast majority of amino acid residues demonstrated minor 
frequency fluctuation over time, consistent with the conservative nature of the HIV-1 Gag 
protein. Only 4.0% (20 out of 500; HXB2 numbering) amino acid residues across Gag 
displayed both statistically significant (p<0.05 by both a trend test and heterogeneity test) 
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changes in amino acid frequency over time as well as a range of at least 10% in the 
frequency of the major amino acid. A total of 59.2% of amino acid residues with changing 
frequency of 10%+ were found within previously identified CTL epitopes. The time of the 
most recent common ancestor of the HIV-1 subtype C was dated to around 1950  
(95% HPD from 1928 to 1962). This study provides evidence for the overall stability of 
HIV-1 subtype C Gag among viruses circulating in the epidemic over the last decade. 
However selected sites across HIV-1C Gag with changing amino acid frequency are likely 
to be under selection pressure at the population level.  
Keywords: HIV-1 subtype C; consensus sequence; amino acid frequency; Gag; gag 
phylogeny; CTL epitopes; time of MRCA 
 
1. Introduction  
The propensity of HIV to generate mutations and escape from immune pressure leads to 
considerable intra-host viral diversification over time. Upon transmission to a new host, the virus may 
restore its wild-type status through reverse mutations, and acquire new escape mutations in response to 
immune pressure from the new host. These dynamic processes underline the perpetual virus–host 
interactions over the endless chain of virus transmissions. Increasing HIV diversity impacts most 
biomedical prevention and therapeutic strategies, and especially affects the design of HIV vaccine 
antigens.  
Because of the complex nature of transmission of HIV in a population, an understanding of the 
dynamics of HIV evolution at the population level is particularly challenging. To shed additional light 
on this, we assess the diversity and time changes of the HIV-1 structural protein Gag, as this is one of 
the most attractive targets for HIV vaccine design. Recent studies have demonstrated that HIV-1 Gag 
can induce potent virus-specific T cell responses, and provided evidence that the breadth, magnitude, 
and functional profile of such immune responses are associated with control of viral replication, low 
viral set point, and better disease prognosis [1-15]. Therefore, better understanding of viral dynamics 
and the in vivo mutational pathways in Gag could further the rational design of an HIV-1 vaccine. We 
also focus on HIV-1 subtype C because it is the predominant viral subtype in the worldwide 
HIV/AIDS epidemic, and the HIV subtype associated with the highest incidence and prevalence rates 
during heterosexual transmission.  
Knowledge of viral mutations directly selected due to their fitness cost and immune pressure could 
aid in the discovery of new approaches to efficient control of HIV. Recent studies addressing the 
natural course of HIV infection and/or utilizing SIV models have shown that virus-specific CD8+ T 
cell responses and neutralizing antibodies are main determinants of HIV evolution on the population 
level in the HIV/AIDS epidemic [16-21]. 
Phylodynamic studies may help to reveal the biological mechanisms underlying observed HIV 
evolution and thereby enable us to better control the HIV/AIDS epidemic. Analysis of viral mutational 
pathways on a population level could lead to better understanding of the limits of viral sequence 
variation and to identification of viral evolutionary space in the HIV/AIDS epidemic. The goal of the 
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current analyses was to investigate how HIV-1 subtype C variation in gag/Gag is modulated by 
epidemic dynamics in order to better understand how stable subtype C consensus is over time, and 
whether amino acid toggling  [21] and/or stochastic mutations  [22] affect its structure and dynamics. 
2. Results and Discussion  
The study addressed the following four aspects of viral diversity: (1) phylogeny and diversity of 
HIV-1 subtype C gag over time; (2) extent of amino acid frequency change in Gag over time at 
specific sites; (3) relationships between changing amino acids in HIV-1 subtype C Gag and CTL 
epitopes; and (4) the date of HIV-1 subtype C divergence. 
2.1. The in vivo dynamics of gag diversity 
The phylogeny of HIV-1 subtype C as the dominant virus in the HIV/AIDS epidemic has been the 
subject of considerable recent interest. In this study we address the following questions: (i) Are there 
lineages or sub-clades within HIV-1 subtype C gag sequences? If so, are sub-clusters within HIV-1 
subtype C associated with geographic origin or time of sampling? Is there a segregation of the C and 
C’ sub-clades from Ethiopia? Are there distinguishable lineages of viruses originating from Southern 
Africa? (ii) What is the match between the traditional tree-based phylogenetic analysis and the split 
network analysis? If there is a conflict, is there evidence for recombination events? (iii) What is the 
extent of viral diversity of contemporaneous HIV-1 subtype C sequences? What is the dynamic of viral 
diversity within gag over time? 
To analyze phylogenetic relationships between HIV-1 subtype C gag sequences, we determined the 
maximum likelihood tree by PhyML [23], with the approximate Likelihood Ratio Test as a statistical 
test for branch support (using a criterion of aLRT>0.90). The maximum likelihood tree is presented in 
Figure 1 with color-coded branches corresponding to different times of sampling, and highlighted 
nodes with aLRT support of more than 0.90. A total of 16 terminal clusters with more than five 
sequences were found with an aLRT value of more than 0.90 (Figure 1). The median (IQR) number of 
sequences in clusters was 15 (7; 22), and ranged from 6 (clusters 5, 6, and 11) to 47 (cluster 12).  
A total of 289 out of 653 (44.3%) analyzed sequences were found in clusters within HIV-1 subtype C, 
which was consistent with our previous report on intra-subtype lineages in subtype C viruses [24].  
HIV-1 subtype C gag sequences representing different time points of sampling were scattered 
throughout the phylogenetic tree without any suggestion of branching topology being related to the 
time of sampling. Although two small clusters (5 and 6) were comprised exclusively of Indian and 
South Africa sequences sampled in 1999, earlier time points were relatively rare at the bottom half of 
the tree. Cluster 16 included only sequences sampled in 2001 and later. Although clusters 5, 6, and 16 
include small numbers of sequences, they might suggest ongoing extinction and evolution of virus 
intra-subtype lineages in the epidemic, highlighting the importance of sequence monitoring. 
Analysis of sequence distribution by the country of origin reveals that viruses from South Africa 
were present in 14 of the 16 clusters, suggesting that extensive sequence analysis is important, and is 
able to reveal distinct lineages within HIV-1 subtype C [24]. Ten of 12 available sequences from 
Ethiopia were equally split between clusters 2 and 3, supporting previous findings of C and C’ viruses 
in this country [25-30]. Interestingly, 16 of 22 sequences from Israel were also split between clusters 2  
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(nine sequences) and 3 (seven sequences) together with the Ethiopian sequences, further supporting 
the existence of distinct lineages within HIV-1 subtype C. Indian sequences did not form a single 
cluster but were present in multiple clusters, suggesting ongoing diversification.  
Figure 1. Phylogenetic relationships between HIV-1 subtype C gag sequences. 
Phylogenetic tree was constructed by PhyML. Color branches represent year of sampling 
by group. Nodes with significant aLRT support are highlighted. 
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We examined the congruence between the topologies of unrooted single phylogenetic tree and split 
network to identify potential deviations from the tree-like structure of analyzed gag sequences. 
Computation of split networks was performed using the NeighborNet approach which represents a 
“hybrid” between the neighbor-joining and split decomposition methods [31]. The resulting 
phylogenetic network produced by SplitsTree v4 [32,33] is presented in Figure 2, and depicts a star-
like phylogeny of analyzed HIV-1 subtype C gag sequences. The central part of the phylogenetic 
network highlights multiple splits and parallel branching, which is consistent with the recent report of 
HIV-1 envelope sequences from subtype B collected in the USA [20]. The observed pattern is a 
signature for a potential conflict between phylogenetic tree and split network. The presence of splits 
provides evidence that the analyzed set of HIV-1 subtype C gag sequences possesses some amount of 
phylogenetic signal in the data that cannot be explained adequately by a single tree. However, since 
the splits are present predominantly in the central part of the split network and the extent of splits is 
moderate, the tree-based phylogenetic analysis is valid. It is likely that the recombination events can be 
found in the analyzed set of gag sequences, and if so, recombination could explain the presence of 
splits. Further analysis using alternative phylogenetic networks including recombination networks 
should help to reconstruct a detailed evolutionary history of HIV-1 subtype C sequences. 
Figure 2. Phylogenetic network of HIV-1 subtype C gag sequences (n=653). The 
presented split network was generated by SplitsTree v4  [32,33] using the NeighborNet 
approach. To highlight multiple splits and parallel branching, the central part of the split 
network is enlarged.  
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To assess viral diversity in HIV-1 subtype C epidemic, we analyzed gag pairwise distances within 
the entire set of sequences and within subsets of sequences grouped by sampling year. The median 
(IQR) pairwise diversity of 653 analyzed subtype C gag sequences was 8.73% (7.65%; 9.84%), 
ranging from 0.07% to 23.9%. The mean value of the overall diversity in gag was 8.8%. Figure 3A 
displays the diversity within subsets of sequences grouped by sampling year. Comparison of pairwise 
distances over different sampling periods reveals a statistically significant (p<0.001 by Mann-Whitney 
Rank Sum test) increase of viral diversity in HIV-1 subtype C gag sequences in the epidemic of about 
1.5% over the last decade (slope of 0.00185 per year).  
Figure 3. Pairwise distances of HIV-1 subtype C gag sequences collected at different time 
points. In the box plots: The boundary of the box closest to zero indicates the 25th 
percentile, a black line within the box marks the median value, a red line within the box 
shows the mean, and the boundary of the box farthest from zero indicates the 75th 
percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Points 
above and below the whiskers indicate the 5th and 95th percentiles. Five groups in each 
graph correspond to the time of sampling. A: Pairwise distances within group by sampling 
time. B: Pairwise distances to HIV-1 subtype C consensus. Comparisons between groups 
are based on Mann-Whitney sum rank test.  
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To evaluate relationships between HIV-1 subtype C consensus (derived from LANL) and actual 
sequences, we analyzed pairwise distances between subtype C gag consensus and analyzed sequences. 
As expected, median (IQR) pairwise distance to subtype consensus was about half of the median value 
among all sequences, 4.88% (4.22%; 5.57%), and had a smaller range, from 2.05% to 12.03%. 
Similarly, distances between subtype consensus and subsets of sequences sampled at different time 
points were approximately half the corresponding distances among subsets of sequences (Figure 3B). 
There was a gradual increase over the decade (slope of 0.00124 per year), with statistically significant 
differences among the more remote subsets, providing evidence for overall diversification of the 
circulating viral sequences in the HIV-1 subtype C epidemic from the previously established subtype 
consensus sequence. The data also suggests the need for a regular update of subtype consensus so as to 
be able to adequately represent circulating viruses. Although our analysis revealed a star-like 
phylogeny of HIV-1 subtype C gag sequences sampled over decade of epidemic, the observed gradual 
increase in mean and median pairwise distances necessitates further screening to exclude virus 
evolving in any specific direction. A designed sample collection can also improve balanced 
representation of different geographic areas and minimize sampling bias in generating the consensus 
sequence. 
The FST statistics was used to assess divergence between earliest, before 2000, and the latest,  
2004-2006, samples. Values of FST were estimated by methods described by Hudson, Slatkin and 
Madison  [34], Slatkin  [35] and Hudson, Boos and Kaplan  [36] and implemented by the HyPhy 
package  [37]. The estimated FST values were 0.027, 0.014, and 0.014 by three mentioned methods, 
respectively, suggesting lack of divergence between the earliest and the latest sample sets. 
2.2. Amino acid frequency in HIV-1 subtype C Gag 
To evaluate viral dynamics on a population level, we compared amino acid frequency in the HIV-1 
subtype C Gag extended consensus sequences corresponding to different sampling times, before 2000, 
2000, 2001–2002, 2003, and 2004–2006. Numbering of amino acid sites across Gag from 1 to 500 
corresponded to the HXB2 numbering system (http://www.hiv.lanl.gov/). Three statistical approaches 
were used for analysis of amino acid frequencies at each residue, the chi-square test, the Cochran-
Armitage trend test, and analysis of the ranges in amino acid frequency over time.  
In the first analysis, we tested, for each residue position, whether the distribution of amino acid 
frequency changes over the five time intervals using the chi-square test for Rx5 tables, where R is the 
number of amino acid types. A total of 44 of 500 (8.8%) amino acid residues across Gag were 
identified with significant (p<0.05) changes in their frequency over time. Changing amino acid 
residues identified by the chi-square test were spread unevenly across Gag: 14 (32%) were located in 
Gag p17, 9 (21%) in p24, 2 (5%) in p2, 2 (5%) in p7, 10 (23%) in p1, and 7 (16%) in p6, accounting 
for 21 (48%) changing amino acid residues in p15. 
In the second analysis, we tested, for each position, whether the frequency of the major amino acid 
changed monotonically (increasing or decreasing) over time, using the Cochran-Armitage trend test. 
With this analysis, a significant (p<0.05) trend was found in 75 (15%) of the 500 positions. The 
distribution of changing amino acid residues across Gag cleavage products was more even: 21 (28%) 
Viruses 2010, 2              
 
 
40
were found in Gag p17, 28 (37%) in p24, 2 (3%) in p2, 3 (4%) in p7, 12 (16%) in p1, and 9 (12%) in 
p6. 
Recognizing that relatively small changes in amino acid frequency over time can sometimes yield 
statistically significant test results, the third analysis examined whether, for each position, the 
frequencies of the major amino acid at different time intervals differed by more than a specified 
amount. A total of 8 of 500 (1.6%) amino acid positions demonstrated a range of frequencies over time 
that is more than 20%, with maximum range of 36% at amino acid position 11 in p17 between 
gradually reducing Gly and increasing Glu on a background of low frequency of Thr, Lys, Asp, and 
Ala. In addition, a total of 41 (8.3%) amino acid positions exhibited ranges in frequency between 10% 
and 20%, while 98 (19.9%) amino acid positions exhibited ranges between 5% to 10%. Analysis of 
amino acid toggling on a population level in the context of dominant HLA alleles can be an important 
direction to be pursued in future studies. 
Combining the results of the statistical tests of heterogeneity/trend and the analyses of magnitude of 
change in amino acid frequency resulted in only 20 of 500 (4.0%) positions which demonstrated 
statistically significant changes by the heterogeneity and trend test as well as a range of amino acid 
frequencies of at least 10%. Figure 4A highlights amino acid positions across Gag that showed 
significant changes in amino acid frequency by any method. Figure 4B provides details of amino acid 
frequency dynamics at 20 positions across Gag that showed significant changes by all three methods. 
To distinguish trends of specific amino acid increase (decrease), which may be more likely as a 
result of directed selection on a population level, from fluctuations in amino acid frequency, which is 
more likely to be a sampling issue, we analyzed the slopes of increasing and decreasing amino acids 
within a subset of 20 amino acid positions with significant changes over time. The median (IQR) 
increasing amino acid slope within the subset was 0.017 (0.012; 0.023), ranging from 0.003 to 0.042. 
This translates into an average increasing rate of selected amino acids within HIV-1 subtype C of 17% 
(12%; 23%) over the decade. The median (IQR) decreasing amino acid slope within the subset of 20 
amino acid positions with significant changes over time was -0.017 (-0.020; -0.014), ranging from  
-0.041 to -0.008, which corresponds to an average 10-year decline 17% (14%, 20%) of selected amino 
acids. 
Taken together, these results indicate a remarkable stability of HIV-1 subtype C consensus over the 
last decade in the HIV-1 subtype C epidemic. A majority of sites across HIV-1 subtype C Gag showed 
minimal changes over time and frequency fluctuations within small ranges. A relatively small number 
of sites across HIV-1 subtype C Gag, 20 (4.0%), demonstrated statistically significant changes in 
amino acid frequency over time that were confirmed by three applied methods (chi-square test, 
Cochran-Armitage test, and analysis of ranges). Patterns of changing amino acids within this subset 
were consistent with expected positive or negative slopes.  
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Figure 4. Changing amino acid residues in HIV-1 subtype C Gag. A: Overview of 
changing amino acid residues across Gag cleavage products. Location of changing amino 
acids is shown in relation to HXB2 numbering. Changing amino acid sites with frequency 
change of more than 20% are shown in red, and sites with frequency change between 10% 
and 20% are shown in blue. Location of changing amino acids detected by chi-square test 
and Cochran-Armitage trend test is depicted in black under the Gag bar. B: Dynamics of 
amino acid frequency at top 20 sites (significant changes by all three methods). Number in 
the upper left corner in each graph depicts location in relation to HXB2 numbering.  
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2.3. Synonymous and non-synonymous changes 
To identify sites under positive or negative selection in HIV-1 subtype C gag we estimated the rates of 
non-synonymous and synonymous changes at each site by using single-likelihood ancestor counting 
method (SLAC) as described by Kosakovsky Pond and Frost  [38]. This analysis revealed 31 
positively selected sites and 242 negatively selected sites that were supported by p-valued of less than 
0.05. All codon positions with significant (p<0.05) positive or negative selection are outlined in  
Figure 5. Seven of the sites presented in Figure 4B were found to be under positive (diversifying) 
selection in the SLAC analysis (positions 11, 62, 91, 111, 215, 286, and 342). Two of the sites 
presented in Figure 4B, positions 28 and 34, were under negative (purifying) selection by SLAC. 
Figure 5. Normalized dN-dS values across gag codons. P-values were derived from a two-
tailed extended binomial distribution. A total of 31 positively and 242 negatively selected 
sites were found. 
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2.4. Changing amino acids and CTL epitopes 
It is believed that changes in amino acid frequency in the global HIV-1 subtype C consensus over 
time are driven by cumulative immune pressure on the population level. MHC class I HLA alleles that 
are associated with control of HIV infection impose the strongest pressure at viral epitopes [20,39]. 
Therefore, it is plausible that changing amino acid residues should be located within the virus-specific 
CTL epitopes. To test this assumption, the Los Alamos National Laboratory HIV immunology 
database (http://www.hiv.lanl.gov/content/immunology; accessed on 14 August 2009) was screened 
for known human CTL epitopes identified in the context of HIV-1 subtype C infection irrespective of 
Viruses 2010, 2              
 
 
43
their MHC class I HLA alleles restriction, and the location of changing amino acids was matched with 
the retrieved epitopes. 
Table 1. Amino acid positions in HIV-1 subtype C Gag with frequency change ≥20% in 
the subtype C consensus sequence: potential association with known CTL epitopes. (Note: 
Epitopes with multiple changing amino acids are highlighted; changing amino acids are 
shown in bold and underscored). 
Gag  
cleavage 
product 
Amino 
acid 
position 
Number of 
associated 
CTL epitopes 
Epitope  HXB2  HIV‐1 
Subtype  HLA restriction start  end 
p17 
11  1  ASILRGGKLDK  5  15  C   
28  10 
RLRPGGKKHY  20  29  C  A*3002 
RLRPGGKKHYM  20  30  C   
RPGGKKHY  22  29  A, C, D  B42, B7 
RPGGKKRYM  22  30  C  B35, Cw*0602 
RPGGKKKYML  22  31  A, C, D  B*0702, B*5801, B*8101 
KRYMIKHLV  27  35  C  Cw*0602 
HYMLKHIVW  28  36  A, C  A*2301 
34  7 
HYMLKHLVW  28  36  A, B, C  A*2301, A*2402, A24 
HYMLNHIVW  28  36  A, C, D  B*0702, B*5801, B*8101 
HYMLKHLVWAS  28  38  C   
HLVWASREL  33  41  C  Cw*0602, Cw*0804 
LVWASRELERF  34  44  C  A*3002, A30, B*5703, B57 
76  2  EELRSLYNTV  73  82  C  B*4006 
RSLYNTVATLY  76  86  B, C  A*30, A*3002, A30, B57, B58, B63 
111  0           
119  0           
p24  342  4 
RALGPGATL  335  343  A, B, C, D  B7 
ALGPGASLEEM  336  346  C   
GPGATLEEM  338  346  A, C, D  B*0702, B*5801, B*8101 
ATLEEMMTA  341  349  B, C, 
CRF01_AE  A*0201, A*0206, A*0220, A*0234, A*0236, A2 
p2  375  0           
 
A relatively high fraction of amino acid residues with changing frequency of 10% and higher, 29 of 
49 (59.2%), was found within previously identified CTL epitopes, including five of eight amino acid 
residues with changing frequency of 20% and higher. Relationships between amino acids with 
frequency change of ≥10% and involved CTL epitopes are presented in Tables 1 (frequency change of 
≥20%) and 2 (frequency change of 10–20%). The location of amino acids is shown within the CTL 
epitopes, and epitopes with multiple changing amino acids are highlighted. Amino acids with changing 
frequency but without matching CTL epitopes reflect gaps in our knowledge regarding HIV-1 Gag-
specific T cell responses. Further studies are warranted to identify mechanisms that drive changes of 
amino acid frequency at the population level. 
The status of a specific well-studied CTL epitopes in HIV-1 Gag is of particular interest. 
Specifically, analysis was performed for 30 well defined epitopes in Gag with HLA-associated 
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polymorphic residues analyzed recently by Brumme et al [40]. A subset of 15 of 30 (50%) epitopes 
included amino acids with changing frequency of 10% and higher, although some changing amino 
acids differed from the HLA-associated polymorphisms within epitopes. For example, within the 
epitope SL9, SLYNTVATL, Tyr at the third position has been a gradually increasing amino acid in 
HIV-1 subtype C over a decade (0.43  0.44  0.50  0.54  0.61), while Ala at the seventh 
position, which is considered to be an HLA-A02-associated residue, stayed relatively stable (0.95  
0.98  0.97  1.0  0.97) over time. Although our analysis did not involve HLA typing data, the 
study results on viral mutations within optimized CTL epitopes are in line with finding by the Philip 
Goulder group on HLA-driven viral evolution  [41]. 
Table 2. Amino acid positions in HIV-1 subtype C Gag with frequency change 10% to 
20% in the subtype C consensus sequence: potential association with known CTL epitopes 
(Note: Epitopes with multiple changing amino acids are highlighted; changing amino acids 
are shown in bold and underscored). 
Gag  
cleavage 
product 
Amino 
acid 
position 
Number of 
associated 
CTL epitopes
Epitope  HXB2  HIV‐1 
Subtype  HLA restriction start  end 
p17 
7  1  ASILRGGKLDK  5  15  C   
15  2  ELDRWEKIRL  12  21  B, C  B63 
18  2  KIRLRPGGKK  18  27  B, C, 
multiple  A*0301, A11, A3, B27 
20  4  RLRPGGKKHY  20  29  C  A*3002 
30  7  RLRPGGKKHYM  20  30  C   
RPGGKKRYM  22  30  C  B35, Cw*0602 
31  6 
RPGGKKKYML  22  31  A, C, D  B*0702, B*5801, B*8101 
KRYMIKHLV  27  35  C  Cw*0602 
HYMLKHIVW  28  36  A, C  A*2301 
HYMLKHLVW  28  36  A, B, C  A*2301, A*2402, A24 
HYMLNHIVW  28  36  A, C, D  B*0702, B*5801, B*8101 
HYMLKHLVWAS  28  38  C   
61  0           
62  0           
65  0           
69  0           
79  6 
EELRSLYNTV  73  82  C  B*4006 
RSLYNTVATLY  76  86  B, C  A*30, A*3002, A30, B57, B58, B63 
SLYNTVATL  77  85 
A, B, C, 
CRF02_AG, 
D, F, G, K 
A*02.01, A*0201, A*0202, A*0205, A*0214, 
A*0220, A*0234, A*0236, A*68, A02, A2, 
B*1503 
SLFNTVATLY  77  86  C   
LYNTVATLY  78  86  C  A*2902, A29, B*4403 
LFNTVATLY  78  86  C  A*2902 
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Table 2. Cont. 
p17 
90  1  YCVHAGIEVRD  86  96  C   
91  1           
93  1           
95  1           
120  0           
p24 
163  8 
VKVIEEKAF  156  164  C  B*1503 
VKVVEEKAF  156  164  B, C  B*1503 
IEEKAFSPEV  159  168  C  B*4006 
IEEKAFSPEVI  159  169  C  B*4501 
EEKAFSPEV  160  168  A, C  B*4415, B*4501 
EKAFSPEV  161  168  C  Cw*0602 
KAFSPEVIPMF  162  172 
A, B, C, 
CRF02_AG, 
G 
A*310102, A*6603, B*440302, B*5701, 
B*5703, B*5801, B57, B58, B63, B8, 
Cw*040101, Cw*07 
AFSPEVIPMFT  163  173  C   
215  3  AAEWDRLHPVH  209  219  C   
AEWDRLHPV  210  218  B, C  A2, B*04, B*4006, Cw*0602 
223  4 
RLHPVHAGPIA  214  224  C   
HPVHAGPIA  216  224  B, C  B*3910, B07, B35, B7 
HPVHAGPVA  216  224  A, B, C, D  B7 
GPIAPGQM  221  228  C, D  B35 
248  3 
TSTLQEQIGW  240  249  B, C, HIV‐2 
A*310102, A*6603, B*440302, B*5701, 
B*5703, B*58, B*5801, B27, B35, B57, B58, 
B63, B7, Cw*040101, Cw*07 
TSTLQEQIAW  240  249  B, C  B*5701, B*5703, B*5801, B57 
TLQEQIGWM  242  250  B, C  A*0201, A*0220, A*0234, A*0236, A2 
260  6 
PPIPVGDIY  254  262  B, C  B*3501, B*3502, B35 
PPVPVGDIY  254  262  C  B35 
PPIPVGEIY  254  262  A, B, C, D  B35, B53, B7 supertype 
PVGDIYKRWII  257  267  C   
GEIYKRWII  259  267 
A, B, C, 
CRF02_AG, 
D 
A*01, A*6801, B*0801, B*51, B8, Cw*07, 
Cw15, DQ2, DQ3, DR3, DR4 
DIYKRWII  260  267  B, C  B*0801, B8 
286  0           
312  3 
TLRAEQATQD  303  312  C  Cw*0304 
RAEQATQDVKN  305  315  C   
QATQDVKNW  308  316  C  B*5301, B*5801, B57 
319  0           
335  2  NPDCKTILRAL  327  337  C  B*3910 
336  1  RALGPGATL  335  343  A, B, C, D  B7 
339  3  ALGPGASLEEM  336  346  C   
GPGATLEEM  338  346  A, C, D  B*0702, B*5801, B*8101 
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Table 2. Cont. 
p2 
370  1  CLAEAMSQV  362  370  B, C  A*0201, A*0220, A*0234, A*0236 
371  0           
374  0           
p7 
377  0           
380  0           
381  0           
389  0           
401  1  IAKNCRAPRKK  401  411  C   
p1  441  1  FLGKIWPSHK  433  442  A, B, C, 
CRF01_AE  A*0201, A*0205, A2 
p6 
451  0           
467  0           
472  0           
490  1  PLTSLKSLFGS  485  495  C   
498  0           
 
2.5. Dating of HIV-1 subtype C divergence 
To assess the date of the HIV-1 subtype C divergence we estimated the time to the most recent 
common ancestor (tMRCA) of subtype C viruses in a subset of 138 gag sequences selected by country 
representation (limit was set to three sequences per country per year of sampling). A relaxed clock 
Bayesian MCMC coalescent framework analysis was implemented in BEAST v1.4.8  [42]. This 
approach incorporates phylogenetic uncertainty and accounts for the possibility of variable substitution 
rates among lineages and differences in the demographic history of the virus, sampling phylogenies 
and parameter estimates in proportion to their posterior probability  [43-46]. Substitution rates were 
calibrated with analyzed gag sequences with known year of sampling. The median (95% highest 
posterior density interval, HPD, a Bayesian analog to a confidence interval) substitution rate in gag 
was estimated as 2.65x10-3 (1.87x10-3-3.49 x10-3) substitutions per site per year. The different 
demographic/coalescent models gave similar estimates for HIV-1 subtype C tMRCA. The tMRCA 
(95% HPD) of HIV-1 subtype C was estimated at 1950 (1930–1962) based on a constant population 
size model and at 1948 (1928–1962) using the Bayesian skyline plot  [47,48] (Figure 6), which is 
consistent with the estimated date of tMRCA of HIV-1 group M  [44].  
HIV-1 viruses evolved from a common ancestor circulating at the beginning of the twentieth 
century  [44] that was acquired by humans through cross-species transmissions followed by a split into 
HIV-1 M group subtypes as a result of founder events  [49,50]. We estimated the date of HIV-1 
subtype C diversification around 1950 (1928–1962). These results are consistent with the notion that 
HIV-1 subtypes underwent several decades of independent evolution in humans  [44,50-52] before 
reaching a sizable HIV/AIDS epidemic. 
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Figure 6. Bayesian skyline plot of HIV-1 subtype C. The upper 95% HPD, median, and 
lower 95% HPD of HIV-1 subtype C are projected on the time line. The bold black line 
traces the inferred median effective population size over time with the 95% HPD shaded in 
blue. 
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A deeper understanding of reasons for the flattening the HIV-1 subtype C population size after 1980 
is of great importance. Theoretical considerations suggest that some sort of evolutionary constraint 
may exist for virus adaptation as a consequence of environmental, selective, genetic, or functional 
trade-offs (e.g., negative epistasis and pleotropy) that can limit viral evolution  [53], and can be one of 
the potential causes for the flattering of the population size. However, this analysis could be 
confounded by the increasing frequency of intra-subtype recombinants that accompany epidemic 
growth. 
3. Experimental Section  
Included HIV-1 subtype C gag sequences. The extended HIV-1 subtype C consensus was generated 
as described elsewhere [24]. A total of 653 unique (one sequence per patient) HIV-1 subtype C 
sequences spanning more than 1,000 bp of gag were retrieved from the Los Alamos HIV Database at 
http://www.hiv.lanl.gov/ (accessed on 14 August 2009) after excluding 42 sequences with indels or 
due to their identity. The country representation of gag sequences included in the analysis is shown in 
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Table 3, and included 431 sequences from South Africa, 49 sequences from Botswana, 41 sequences 
from India, 30 sequences from Zambia, 22 sequences from Israel, 18 sequences from Tanzania, 12 
sequences from Ethiopia, 11 sequences from Malawi, and small numbers of sequences from Argentina 
(2), Brazil (6), China (2), Cyprus (5), Djibouti (1), Denmark (2), Spain (3), Georgia (1), Kenya (3), 
Senegal (1), Somalia (1), Uganda (2), USA (2), Uruguay (1), Yemen (1), and Zimbabwe (6). Sampling 
time of the retrieved sequences is also presented in Table 3. Most of the retrieved samples were 
sampled between 1998 and 2005. For analysis of viral dynamics the retrieved sequences were grouped 
by their sampling time. The 2007–2008 group included only five sequences, and was not used in the 
analysis of amino acid frequencies. The extended consensus sequence was built for each group. 
Frequencies of amino acid at each residue position were expressed as a fraction of 1. The low 
threshold of detection was 0.005.  
Table 3. HIV-1 subtype C gag sequences (>1,000 bp) included in the analyses by country 
of origin and by year of sampling. Countries with fewer than 10 sequences are presented as 
‘Others’, and include Argentina (2), Brazil (6), China (2), Cyprus (5), Denmark (2), 
Djibouti (1), Georgia (1), Kenia (3), Senegal (1), Somalia (1), Spain (3), Uganda (2), USA 
(2), Uruguay (1), Yemen (1), and Zimbabwe (6). Groups of analyzed gag sequences by 
sampling year are outlined at the bottom.  
Country  n  19
86
 
19
87
 
19
88
 
19
89
 
19
90
 
19
91
 
19
92
 
19
93
 
19
94
 
19
95
 
19
96
 
19
97
 
19
98
 
19
99
 
20
00
 
20
01
 
20
02
 
20
03
 
20
04
 
20
05
 
20
06
 
20
07
 
20
08
 
Botswana  49  10  7  4  25  3 
Ethiopia  12  1  4  3  1  1  2 
India  41  4  5  2  23  4  2  1 
Israel  22  1  4  17 
Malawi  11  1  3  7 
South Africa  431  3  17  27  72  73  22  111  79  24  3 
Tanzania  18  2  11  5 
Zambia  30  1  1  6  11  8  3 
Others:  39  1  2  2  1  5  0  4  6  2  2  5  2  5  1  1 
Total:  653  1  0  5  1  2  2  1  5  5  0  14  4  34  58  131  111  39  117  84  26  8  4  1 
 
 
 
Viral diversity. Retrieved HIV-1 subtype C gag nucleotide sequences were aligned using 
Muscle [54] followed by a BioEdit [55] manual adjustment. The maximum-likelihood (ML) method 
was used to estimate pairwise nucleotide distances. Evolutionary model was selected by using the 
Akaike information criterion in jModeltest 0.1.1 [56]. The parameters of the model (TPM1uf+Ι+Γ) 
were as follows: nucleotide frequencies, ƒA=0.4014, ƒC= 0.2286, ƒG=0.1962, and ƒT=0.1738; estimated 
value of shape parameter α of the Γ distribution = 0.5510; estimated value of proportion of invariable 
sites = 0.170; R matrix values, RA↔C = 1.0; RA↔G = 4.4966; RA↔T = 0.6194; RC↔G = 0.6194; RC↔T = 
4.4966; and RG↔T = 1.0. The identified substitution model was used in PAUP* version 4.0b10  [57] to 
  Before 2000: 132 sequences
20
01
‐20
02
: 
15
0 
20
00
: 13
1  2004‐2006: 
118 
20
03
: 11
7 
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estimate ML-corrected pairwise distances. The majority consensus sequence for the earliest 
quasispecies was built in BioEdit.  
Phylogenetic analysis. The genealogy reconstruction of the analyzed gag sequences was 
implemented in PhyML [23] using the HKY model of nucleotide substitution. The maximum 
likelihood tree was visualized by FigTree [58]. The potential disagreement between phylogenetic tree 
and phylogenetic network was tested by SplitsTree v4 [32,33] using the NeighborNet approach.  
Rates of non-synonymous and synonymous changes. A subset of 138 gag sequences was selected by 
country representation (limit was set to three sequences per country per year of sampling). A single 
likelihood ancestor counting, SLAC, method was used as described in  [38]. A global MG94 model 
was fitted for the entire gag alignment and was used for maximum likelihood reconstruction of 
ancestral codons. We inferred selection by SLAC using methods described in  [59]. 
Estimating time of the most recent common ancestor of HIV-1 subtype C. The phylogeny and 
divergence time were estimated using the Bayesian MCMC inference under a 'relaxed' molecular clock 
model, as implemented in BEAST v1.4.8  [42,43]. Analysis was performed under an uncorrelated 
lognormal relaxed molecular clock model, using a general time-reversible nucleotide substitution 
model, estimated base frequencies, and heterogeneity among sites modeled with a gamma distribution. 
The demographic models of constant population size and Bayesian skyline plot were used. Alternative 
demographic models (exponential growth, expansion growth, and logistic growth) were not utilized 
because their use was shown to provide similar results in estimating time of the most recent common 
ancestor for HIV-1 group M  [44]. Runs of 20 million steps each were performed, and the MCMC 
samples were inspected with Tracer v1.4.1 (Andrew Rambaut and Alexei Drummond), which 
indicated convergence and adequate mixing of the Markov chains, with high values of estimated 
sample sizes. The Bayesian skyline reconstruction was performed by Tracer v1.4.1. 
Statistical methods. Data are summarized with medians (IQR). Comparisons between groups of 
sequences with different time of sampling were based on Mann-Whitney Rank Sum tests. Comparison 
of amino acid frequency in the subtype C extended consensus sequence was performed by the chi-
square test for RxC tables and the Cochran-Armitage trend test. All reported p-values are 2-sided. 
4. Conclusions  
The study provides evidence for the overall stability of HIV-1 subtype C Gag among viruses 
circulating in the epidemic over the last decade. However, selected sites across HIV-1C Gag with 
changing amino acid frequency are likely to be under selection pressure on the population level. The 
time of the most recent common ancestor of HIV-1 subtype C viruses was dated to around 1950 (95% 
HPD 1928–1962).  
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